Article Versions Notes

Huang RR, Spliedt M, Kaufman T, Gorlatov S, Barat B, Shah K, Gill J, Stahl K, DiChiara J, Wang Q, et al. A Strategy for Simultaneous Engineering of Interspecies Cross-Reactivity, Thermostability, and Expression of a Bispecific 5T4 x CD3 DART^® Molecule for Treatment of Solid Tumors. Antibodies. 2025; 14(1):7. https://doi.org/10.3390/antib14010007

Huang, Renhua R., Michael Spliedt, Tom Kaufman, Sergey Gorlatov, Bhaswati Barat, Kalpana Shah, Jeffrey Gill, Kurt Stahl, Jennifer DiChiara, Qian Wang, and et al. 2025. "A Strategy for Simultaneous Engineering of Interspecies Cross-Reactivity, Thermostability, and Expression of a Bispecific 5T4 x CD3 DART^® Molecule for Treatment of Solid Tumors" Antibodies 14, no. 1: 7. https://doi.org/10.3390/antib14010007

Huang, R. R., Spliedt, M., Kaufman, T., Gorlatov, S., Barat, B., Shah, K., Gill, J., Stahl, K., DiChiara, J., Wang, Q., Li, J. C., Alderson, R., Moore, P. A., Brown, J. G., Tamura, J., Zhang, X., Bonvini, E., & Diedrich, G. (2025). A Strategy for Simultaneous Engineering of Interspecies Cross-Reactivity, Thermostability, and Expression of a Bispecific 5T4 x CD3 DART^® Molecule for Treatment of Solid Tumors. Antibodies, 14(1), 7. https://doi.org/10.3390/antib14010007